COST-EFFECTIVENESS OF PLERIXAFOR PLUS GCSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MYELOMA AND LYMPHOMA IN SPAIN

被引:0
|
作者
Duarte, R. F. [1 ]
Perez-Simon, J. A. [2 ]
Martin, G. [3 ]
de la Rubia, J. [4 ]
Marin, P. [5 ]
Alvarez, M. A. [6 ]
Espinos, B. [7 ]
Roset, M. [7 ]
机构
[1] Hosp Duran & Reynals, Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] Banc Sang & Teixits, Barcelona, Spain
[4] Hosp Univ La Fe Valencia, Valencia, Spain
[5] Hosp Clin Barcelona, Barcelona, Spain
[6] Hosp Reina Sofia, Cordoba, Spain
[7] IMS Hlth, Barcelona, Spain
关键词
D O I
10.1016/j.jval.2012.08.2118
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A423 / A423
页数:1
相关论文
共 50 条
  • [41] NEW MOBILIZATION STRATEGIES FOR COLLECTION OF PERIPHERAL BLOOD PROGENITOR CELLS FOR LYMPHOMA AND MYELOMA PATIENTS
    Smith, V. R.
    Hosing, C.
    Popat, U.
    Schindler, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 29 - 29
  • [42] SUCCESSFUL PERIPHERAL BLOOD STEM CELL HARVEST IN MOBILIZATION-REFRACTORY LYMPHOMA AND MYELOMA PATIENTS
    Segel, E.
    Sorensen, B. S.
    Ebbesen, L. H.
    D'Amore, F.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S76 - S77
  • [43] Intermediate dose cyclophosphamide plus growth factor for mobilization of blood stem cells: Analysis of 52 patients with myeloma and lymphoma
    Remes, K
    Salminen, E
    Itala, M
    Kauppila, M
    Matinlauri, I
    Vanharanta, R
    Pelliniemi, TT
    Rajamaki, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 343 - 343
  • [44] Plerixafor for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
    Choi, Hye-Yoon
    Yong, Chul-Soon
    Yoo, Bong Kyu
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) : 117 - 126
  • [45] A Randomized trial comparing the effectiveness of peripheral blood stem cell mobilization with chemotherapy and early vs delayed initiation of granulocyte colony-stimulating factor (GCSF) in patients with lymphoma and multiple myeloma
    Bence-Bruckler, IA
    McDiarmid, S
    Atkins, HL
    Sabloff, M
    Gauthier, I
    Huebsch, LB
    BLOOD, 2005, 106 (11) : 822A - 822A
  • [46] Plerixafor A Review of its Use in Stem-Cell Mobilization in Patients with Lymphoma or Multiple Myeloma
    Keating, Gillian M.
    DRUGS, 2011, 71 (12) : 1623 - 1647
  • [47] Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients
    Malik, Shahbaz A.
    Yanovich, Saul
    Rapoport, Aaron P.
    Badros, Ashraf Z.
    Hardy, Nancy M.
    Kocoglu, Mehmet H.
    Duffy, Alison
    Ruehle, Kathleen
    Nishioka, Jennifer
    Goloubeva, Olga
    Yared, Jean
    BLOOD, 2015, 126 (23)
  • [48] STEM CELL MOBILIZATION WITH PLERIXAFOR IN PATIENTS WITH MYELOMA AND LYMPHOMA - A SINGLE-CENTER RETROSPECTIVE ANALYSIS
    Vucinic, Vladan
    Drechsler, Andre
    Remane, Yvonne
    Bach, Enrica
    Brueckner, Mandy
    Kirchberg, Janine
    Jentzsch, Madlen
    Ramdohr, Florian
    Heyn, Simone
    Wang, Song-Yau
    Schwind, Sebastian
    Herling, Marco
    Metzeler, Klaus
    Franke, Georg-Nikolaus
    Poenisch, Wolfram
    Niederwieser, Dietger
    Merz, Maximilian
    Platzbecker, Uwe
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 613 - 614
  • [49] Etoposide for mobilization of peripheral blood stem cells in patients with de novo multiple myeloma
    Ladeb, S.
    Ben Abdejlil, N.
    Barhoumi, W.
    Barred, E.
    Maammar, M.
    Torjman, L.
    Lakhal, A.
    Jenhani, F.
    Mojaat, N.
    Hmida, S.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S206 - S206
  • [50] Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma
    Ri, Masaki
    Matsue, Kosei
    Sunami, Kazutaka
    Shimazaki, Chihiro
    Hayashi, Akio
    Sunaga, Yoshinori
    Sasaki, Toru
    Suzuki, Kenshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 562 - 572